Quantcast

Latest tuberculosis Stories

2014-10-30 00:20:40

New white paper documents Lilly's philanthropic effort to expand access to multidrug-resistant tuberculosis medicines INDIANAPOLIS, Oct. 30, 2014 /PRNewswire/ -- Today Eli Lilly and Company (NYSE: LLY) published details of its long-standing technology transfer program to increase the global supply of medicines for multidrug-resistant tuberculosis (MDR-TB). Begun in 2003, the effort included Lilly donating manufacturing technology and know-how for two antibiotics to pharmaceutical...

2014-10-28 16:26:51

HILDEN, Germany and BARCELONA, Spain, October 28, 2014 /PRNewswire/ -- - New WHO guidelines launched for prevention include screening and treating for latent TB infection to avert progression to active disease, supporting the implementation of the Post-2015 strategy - QIAGEN will support implementation of new guidelines with awareness campaigns and educational programs, improved access to QuantiFERON(R)-TB Gold, research...

2014-10-28 08:34:03

SUNNYVALE, Calif. and GENEVA, Switzerland, Oct. 28, 2014 /PRNewswire/ -- Cepheid (Nasdaq: CPHD), FIND, and Rutgers New Jersey Medical School, today announced details of a collaboration to develop Xpert(®) MTB/RIF Ultra, a next-generation test for Mycobacterium tuberculosis (TB) with increased sensitivity to aid in detection of patients with smear-negative TB, which is often associated with HIV co-infection. The collaboration is also receiving additional support from the National Institute...

2014-10-10 08:24:09

MONTREAL, Oct. 10, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC: PNK:BNHLF) today announced that The Journal of Urology has accepted for publication a manuscript entitled: Efficacy and Safety of MCNA in Patients with Non-Muscle Invasive Bladder Cancer at High-Risk of Recurrence and Progression Who Have Failed Treatment with Bacillus Calmette-Guérin. An unedited version of the paper is now available for review and citation online at www.jurology.com...

2014-10-09 08:26:50

KNCV Tuberculosis Foundation will lead 525 million dollar TB control program THE HAGUE, The Netherlands, October 9, 2014 /PRNewswire/ -- KNCV Tuberculosis Foundation (KNCV), the Dutch NGO specialized in the fight against tuberculosis, will be the prime partner for the United States Agency for International Development (USAID) in their new five year flagship program 'Challenge TB'. TB is still a deadly infectious disease, killing over 1.3 million people every year worldwide. In...

2014-10-08 16:27:28

ANAHEIM, Calif., Oct. 8, 2014 /PRNewswire/ -- Headquartered in Anaheim, California, WholeHealth Products. (OTC: GWPC) is a diversified company comprised of several specialized partners focused on leveraging the power and convenience of advanced technology and the proven expertise of its team of professionals to improve the fundamental business of health and wellness. WholeHealth Products' line of more than 10 professional diagnostic tests for hospitals, doctors, clinics and healthcare...

2014-09-30 23:07:54

Tuberculosis kills over one million people a year. In North Korea, The Eugene Bell Foundation of Washington, D.C. is working to stop the spread of the deadly disease. Washington, DC (PRWEB) September 30, 2014 A group of Americans is headed to a remote part of the world to combat an epidemic that, left unchecked, could create a catastrophic, global pandemic. No, it’s not Ebola and no, they are not headed to Africa. John Rogers, the Executive Director the Eugene Bell Foundation and his...

2014-09-24 08:28:03

Extending Longstanding Partnership, SAP is Founding Member of The Global Fund's New Coalition Uniting Private Sector to Support Disease Prevention and Treatment Efforts WALLDORF, Germany, Sept. 24, 2014 /PRNewswire/ -- The Global Fund is an international financing organization started in 2002 to fight AIDS, tuberculosis (TB) and malaria. SAP SE (NYSE: SAP) today announced that SAP technology is helping the organization more simply understand how its financial investments are being...

2014-09-22 12:28:17

New multi-year grant continues work to study pressing public health crisis TUCSON, Ariz., Sept. 22, 2014 /PRNewswire-USNewswire/ -- The Critical Path Institute (C-Path), an independent, non-profit organization that works to accelerate the speed of drug and medical product development, today announced it has received a three-year grant renewal from the Bill & Melinda Gates Foundation. The grant will support continued work to advance the science and regulatory pathways leading to...

2014-09-19 23:05:05

To reduce the burden of tuberculosis and address the issue of drug-resistant TB in the Kyrgyz Republic, Abt Associates has been awarded the U.S. Agency for International Development (USAID)-funded Kyrgyzstan TB Program under a five-year cooperative agreement with total funding of $12.7 million. BETHESDA, MD (PRWEB) September 19, 2014 Kyrgyzstan has one of the highest rates of tuberculosis in Central Asia. To reduce the burden of tuberculosis (TB) and address the issue of drug-resistant TB...


Latest tuberculosis Reference Libraries

72_0ab04c9452ae9b3c6ae51f6deb1bcc35
2011-04-25 16:19:14

Mycobacterium tuberculosis (MTB) is a pathogenic bacterial species in the genus Mycobacterium and the causative agent of most cases of tuberculosis. Robert Koch first discovered it in 1882 and that it had an unusual, waxy coating on the cell surface which makes them impossible to Gram stain. M. tuberculosis is highly aerobic and requires high levels of oxygen. It generally infects the respiratory system of mammals. Tuberculin skin test, acid-fast stain, and chest radiographs are the most...

45_255d6ba67dfe6f32b9c7c31f338bf912
2011-04-18 22:11:24

Mycobacterium bovis is a slow-growing, aerobic bacterium and the causative agent of tuberculosis in cattle. Similar to M. tuberculosis, M. bovis can jump the species barrier and cause tuberculosis in humans. It is estimated that M. bovis was responsible for more losses among farm animals than all other diseases combined in the first half of the 20th century. Infection happens after bacterium is ingested. It is generally transmitted to humans via infected milk. Actual human infections are...

More Articles (2 articles) »
Word of the Day
maffling
  • To stammer.
  • Present participle of maffle, to stammer.
  • A simpleton.
The word 'maffle' may come from a Dutch word meaning 'to move the jaws' or a French word meaning 'having large cheeks'.